Search Results | Blood | American Society of Hematology

1-20 of 54

2 3

Sort by

Sort Order Select

Journal Articles

Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Kimimori Kamijo, Yoshimitsu Shimomura, Sung-Won Kim, Takahide Ara, Jun Ishikawa, Tetsuya Eto, Nobuhiro Hiramoto, Ishikazu Mizuno, Shigeru Kusumoto, Yasunori Ueda, Ken-ichi Matsuoka, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Eisei Kondo

Blood (2022) 140 (Supplement 1): 2393–2394.

DOI: https://doi.org/10.1182/blood-2022-159411

Published: 2022

Journal Articles

Indirectly Recognizable Epitopes Derived from Recipient Mismatched HLA-B Are Associated with Adverse Prognosis in Single-Unit Cord Blood Transplantation

Takeshi Sugio, Koji Kato, Naoyuki Uchida, Kohta Miyawaki, Matthias Niemann, Eric Spierings, Makoto Onizuka, Yasufumi Uehara, Masatsugu Tanaka, Noriko Doki, Tetsuya Eto, Hikaru Kobayashi, Yumiko Maruyama, Tatsuo Ichinohe, Junya Kanda, Yoshiko Atsuta, Satoko Morishima

Blood (2022) 140 (Supplement 1): 893–894.

DOI: https://doi.org/10.1182/blood-2022-164913

Published: 2022

Journal Articles

Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

Blood (2022) 140 (Supplement 1): 10598–10600.

DOI: https://doi.org/10.1182/blood-2022-158213

Published: 2022

Journal Articles

Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia

Blood (2021) 138 (Supplement 1): 1790.

DOI: https://doi.org/10.1182/blood-2021-147645

Published: 2021

Journal Articles

Impact of Human Leukocyte Antigen Epitope Matching on Outcomes after Unrelated Bone Marrow Transplantation

Makoto Iwasaki, Junya Kanda, Hidenori Tanaka, Takero Shindo, Noriko Doki, Takahiro Fukuda, Yukiyasu Ozawa, Tetsuya Eto, Naoyuki Uchida, Yuta Katayama, Keisuke Kataoka, Makoto Onizuka, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima

Blood (2021) 138 (Supplement 1): 3914.

DOI: https://doi.org/10.1182/blood-2021-145686

Published: 2021

Journal Articles

Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML

Kyoko Fuse, MD PhD, Masayoshi Masuko, MD PhD, Shohei Mizuno, MD PhD, Kaito Harada, MD, Naoyuki Uchida, MD PhD, Noriko Doki, MD PhD, Takahiro Fukuda, Masatsugu Tanaka, MD, Yukiyasu Ozawa, MD PhD, Kazuhiro Ikegame, MD PhD, Tetsuya Eto, MD PhD, Yoshinobu Kanda, MD PhD, Tatsuo Ichinohe, Yoshiko Atsuta, MD PhD, Masamitsu Yanada, MD PhD

Blood (2020) 136 (Supplement 1): 40–41.

DOI: https://doi.org/10.1182/blood-2020-138979

Published: 2020

Journal Articles

Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm

Hiroyuki Muranushi, MD, Takero Shindo, MD PhD, Masakatsu Hishizawa, MD PhD, Masahito Tokunaga, MD PhD, Atsushi Wake, MD PhD, Nobuaki Nakano, MD, Tetsuya Eto, MD PhD, Michihiro Hidaka, MD PhD, Ilseung Choi, MD PhD, Toshihiro Miyamoto, MD PhD, Naoyuki Uchida, MD PhD, Yukiyoshi Moriuchi, MD, Yasuhiko Miyazaki, MD PhD, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, MD PhD, Koji Kato, MD PhD

Blood (2019) 134 (Supplement_1): 2008.

DOI: https://doi.org/10.1182/blood-2019-123318

Published: 2019

Journal Articles

Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Japan

Shohei Mizuno, MD PhD, Masamitsu Yanada, Koji Kawamura, Shingo Yano, MD PhD, Masayoshi Masuko, MD, Naoyuki Uchida, MD PhD, Yukiyasu Ozawa, MD PhD, Koji Iwato, Kazuteru Ohashi, MD PhD, Kazuhiro Ikegame, MD PhD, Sung-Won Kim, MD PhD, Masatsugu Tanaka, MD, Tetsuya Eto, MD PhD, Yoshinobu Kanda, MD PhD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Akiyoshi Takami, MD

Blood (2019) 134 (Supplement_1): 2045.

DOI: https://doi.org/10.1182/blood-2019-122801

Published: 2019

Journal Articles

Impact of Homozygous Conserved Extended HLA Haplotypes on Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation

Yasuo Morishima, MD PhD, Satoko Morishima, MD PhD, Makoto Murata, MD PhD, Nobuyoshi Arima, MD PhD, Naoyuki Uchida, MD PhD, Yuji Ohno, MD PhD, Satoshi Takahashi, MD PhD, Yoshiko Matsuhashi, MD PhD, Makoto Onizuka, MD PhD, Tetsuya Eto, MD PhD, Yoshiko Atsuta, MD PhD, Takahiro Fukuda, MD PhD, Tatsuo Ichinohe, MD PhD, Shunichi Kato, MD PhD, Junya Kanda, MD

Blood (2018) 132 (Supplement 1): 2097.

DOI: https://doi.org/10.1182/blood-2018-99-110193

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Myelodysplastic Syndrome in Adolescent and Young Adult Patients

Yoshimitsu Shimomura, MD, Masahiko Hara, Takaaki Konuma, MD PhD, Hidehiro Itonaga, MD, PhD, Kazuteru Ohashi, MD PhD, Yukiyasu Ozawa, MD PhD, Tetsuya Eto, MD PhD, Naoyuki Uchida, MD PhD, Takehiko Mori, MD PhD, Junji Tanaka, MD PhD, Takahiro Fukuda, MD PhD, Yoshiko Atsuta, MD PhD, Takayuki Ishikawa, Ken Ishiyama, MD PhD

Blood (2018) 132 (Supplement 1): 3452.

DOI: https://doi.org/10.1182/blood-2018-99-113275

Published: 2018

Journal Articles

Epidemiology of Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed Myelodysplastic Syndrome

Yoshimitsu Shimomura, MD, Masahiko Hara, Takayoshi Tachibana, MD, Kazuteru Ohashi, MD PhD, Yukiyasu Ozawa, MD PhD, Tetsuya Eto, MD PhD, Naoyuki Uchida, MD PhD, Takehiko Mori, MD PhD, Junya Kanda, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Takayuki Ishikawa, Ken Ishiyama, MD PhD

Blood (2018) 132 (Supplement 1): 3453.

DOI: https://doi.org/10.1182/blood-2018-99-113258

Published: 2018

Journal Articles

Reduced-Intensity Allogeneic HSCT for Children and Adolescents/Young Adults with CML: A Study from the Adult and Pediatric CML Working Group of the Japan Society for Hematopoietic Cell Transplantation

Hiroyuki Shimada, MD PhD, Akihiko Tanizawa, MD PhD, Takeshi Kondo, MD PhD, Hideki Muramatsu, MD PhD, Masahiro Yasui, MD, Arinobu Tojo, MD PhD, Tokiko Nagamura-Inoue, MD PhD, Tetsuya Eto, MD PhD, Aiko Igarashi, MD, Heiwa Kanamori, MD PhD, Maho Sato, MD, Maiko Noguchi, MD, Tatsuo Ichinohe, MD PhD, Masami Inoue, MD, Koji Kato, MD PhD, Yoshiko Atsuta, MD PhD, Kazuteru Ohashi, MD PhD

Blood (2018) 132 (Supplement 1): 3008.

DOI: https://doi.org/10.1182/blood-2018-99-117836

Published: 2018

Journal Articles

Impact of Pretransplant HTLV-1 Seropositivity on Hematopoietic Stem Cell Transplantation for the Diseases Other Than ATLL- an Analysis on Behalf of JSHCT Complication Working Group-

Nobuaki Nakano, MD, Hideki Nakasone, MD PhD, Shigeo Fuji, MD PhD, Akihito Shinohara, MD PhD, Ritsuro Suzuki, MD PhD, Atae Utsunomiya, MD PhD, Tetsuya Eto, MD PhD, Yasushi Sawayama, MD, PhD, Sawako Nakachi, MD PhD, Naoyuki Uchida, MD PhD, Takahiro Fukuda, MD PhD, Junya Kanda, MD, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD

Blood (2018) 132 (Supplement 1): 4641.

DOI: https://doi.org/10.1182/blood-2018-99-114111

Published: 2018

Journal Articles

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Koji Nagafuji, MD PhD, Toshihiro Miyamoto, MD PhD, Tetsuya Eto, MD PhD, Ryosuke Ogawa, MD PhD, Naoyuki Uchida, MD PhD, Ken Takase, MD, Noriaki Kawano, MD PhD, Tomoaki Fujisaki, MD PhD, Tomohiko Kamimura, MD PhD, Atsushi Wake, MD PhD, Hirokazu Okumura, MD PhD, Yasuhiko Miyazaki, MD PhD, Yasushi Takamatsu, MD PhD, Toshiro Kurokawa, MD PhD, Yuju Ohno, MD PhD, Shouhei Yokota, MP.Path, Koichi Akashi, MD PhD

Blood (2018) 132 (Supplement 1): 3970.

DOI: https://doi.org/10.1182/blood-2018-99-112848

Published: 2018

Journal Articles

Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma

Hiroo Katsuya, Mototsugu Shimokawa, Kenji Ishitsuka, Kazuhiro Kawai, Masahiro Amano, Atae Utsunomiya, Ryosuke Hino, Shuichi Hanada, Tatsuro Jo, Kunihiro Tsukasaki, Yukiyoshi Moriuchi, Eisaburo Sueoka, Shinichiro Yoshida, Hitoshi Suzushima, Masaharu Miyahara, Kiyoshi Yamashita, Tetsuya Eto, Junji Suzumiya, Kazuo Tamura

Blood (2017) 130 (1): 39–47.

DOI: https://doi.org/10.1182/blood-2017-01-757542

Published: 2017

Includes: Supplemental data

Journal Articles

Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older

Koji Kawamura, MD, Shinichi Kako, MD, Shuichi Mizuta, MD PhD, Ken Ishiyama, MD PhD, Jun Aoki, MD, Shingo Yano, MD PhD, Takahiro Fukuda, MD, Naoyuki Uchida, MD PhD, Yukiyasu Ozawa, MD PhD, Tetsuya Eto, MD PhD, Koji Iwato, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2016) 128 (22): 3414.

DOI: https://doi.org/10.1182/blood.V128.22.3414.3414

Published: 2016

Journal Articles

Safety and Efficacy of a Switch to Nilotinib in Patients with CML-CP Showing MMR to Imatinib: Results of a Multicenter Phase II Trial (NILSw Trial)

Hirohiko Shibayama, MD PhD, Tatsuya Kawaguchi, MD PhD, Junya Kuroda, MD PhD, Hirohisa Nakamae, MD PhD, Itaru Matsumura, MD PhD, Toshihiro Miyamoto, MD PhD, Jun Ishikawa, MD PhD, Tomohiko Kamimura, MD PhD, Kentaro Fukushima, MD PhD, Yutaka Imamura, MD PhD, Tetsuya Eto, MD PhD, Kazutaka Sunami, MD PhD, Mototsugu Shimokawa, PhD, Koichi Akashi, MD PhD, Yuzuru Kanakura, MD PhD

Blood (2016) 128 (22): 1914.

DOI: https://doi.org/10.1182/blood.V128.22.1914.1914

Published: 2016

Journal Articles

Impact of Chromosomal Abnormalities in Acute and Lymphoma Types Adult T-Cell Leukemia-Lymphoma

Blood (2016) 128 (22): 4123.

DOI: https://doi.org/10.1182/blood.V128.22.4123.4123

Published: 2016

Journal Articles

Treatment and survival among 1594 patients with ATL

Blood (2015) 126 (24): 2570–2577.

DOI: https://doi.org/10.1182/blood-2015-03-632489

Published: 2015

Includes: Supplemental data

Journal Articles

Impact of Unbalanced Translocation Der(1;7)(q10;p10) and -7/Del(7q) on the Prognostic Value after Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes: A Nationwide Retrospective Study

Hidehiro Itonaga, MD PhD, Kazunari Aoki, MD, Jun Aoki, MD, Ken Ishiyama, MD PhD, Takayuki Ishikawa, MD, PhD, Kazuteru Ohashi, MD FACP, Takahiro Fukuda, MD, Yukiyasu Ozawa, MD, Naoki Kobayashi, MD, Naoyuki Uchida, Tetsuya Eto, MD PhD, Minoko Takanashi, MD PhD, Tatsuo Ichinohe, MDPhD, Yoshiko Atsuta, MDPhD, Yasushi Miyazaki, MD PhD

Blood (2015) 126 (23): 3206.

DOI: https://doi.org/10.1182/blood.V126.23.3206.3206

Published: 2015

2 3

NARROW

Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Indirectly Recognizable Epitopes Derived from Recipient Mismatched HLA-B Are Associated with Adverse Prognosis in Single-Unit Cord Blood Transplantation

Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia

Impact of Human Leukocyte Antigen Epitope Matching on Outcomes after Unrelated Bone Marrow Transplantation

Significance of Marker Chromosome on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for AML

Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm

Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Japan

Impact of Homozygous Conserved Extended HLA Haplotypes on Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Myelodysplastic Syndrome in Adolescent and Young Adult Patients

Epidemiology of Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed Myelodysplastic Syndrome

Reduced-Intensity Allogeneic HSCT for Children and Adolescents/Young Adults with CML: A Study from the Adult and Pediatric CML Working Group of the Japan Society for Hematopoietic Cell Transplantation

Impact of Pretransplant HTLV-1 Seropositivity on Hematopoietic Stem Cell Transplantation for the Diseases Other Than ATLL- an Analysis on Behalf of JSHCT Complication Working Group-

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma

Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older

Safety and Efficacy of a Switch to Nilotinib in Patients with CML-CP Showing MMR to Imatinib: Results of a Multicenter Phase II Trial (NILSw Trial)

Impact of Chromosomal Abnormalities in Acute and Lymphoma Types Adult T-Cell Leukemia-Lymphoma

Treatment and survival among 1594 patients with ATL

Impact of Unbalanced Translocation Der(1;7)(q10;p10) and -7/Del(7q) on the Prognostic Value after Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes: A Nationwide Retrospective Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only